Dr. Kenneth O’Byrne says research shows novel method for analyzing tissue samples may help predict immunotherapy response. Read more
Dr. Charles Rudin says early data look promising for I-DXd in patients with ES-SCLC. Read more
Drs. Ramaswamy Govindan, Richard Haspel, and Aparna Sharma took the audience on a guided tour of pragmatic lung cancer genomics. Read more
Drs. Isabelle Opitz, Umberto Malapelle, Noemi Reguart, and Jarushka Naidoo will co-chair the event, which will return to Barcelona next September. Read more
During the session, Dr. Hisao Asamura reviewed the criteria changes in the new 9th edition of the TNM classification recommendations. Read more
Dr. Gerrina Ruiter says zongertinib shows encouraging preliminary findings in patients with HER2-mutated NSCLC. Read more
Dr. Xiuning Le presented data from a first-in-human trial that show a rapid, durable response in HER2-mutated NSCLC. Read more
Dr. Shan Xiong says the technology achieved robust and superior predictive performance across cancer genes of diverse types and across racial backgrounds. Read more
The IASLC’s Supportive Training for Advocates on Research and Science Program Provides Tools, Resources, and Education to Aspiring Patient Research Advocates. Read more
A special plenary at WCLC 2024 recognized a half-century of advances in thoracic oncology while reflecting on how far the IASLC has come since its first meeting. Read more